Insulet Corporation (PODD) Stock Analysis

Insulet Corporation (PODD) is a publicly traded company in the HEALTHCARE sector. It trades at $142.43, carries a market capitalization of $10.26B, a price-to-earnings ratio of 34.61. This page summarizes the public market data, fundamentals, and frequently asked questions for PODD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $142.43
• Market Cap: $10.26B
• P/E Ratio: 34.61
• EPS: $4.28
• 52-Week High: $354.88
• 52-Week Low: $140.63

Market Sentiment

Insulet Corporation currently has a Neutral sentiment score of -0.14.

About Insulet Corporation

Insulet Corporation (PODD) is a pioneering company in the field of insulin delivery systems, dedicated to enhancing the quality of life for individuals with insulin-dependent diabetes through innovative technology. Based in Acton, Massachusetts, Insulet is renowned for its Omnipod® Insulin Management System, a revolutionary tubeless, wearable pump that provides patients with unprecedented flexibility and ease of use. With a robust commitment to advancing diabetes care, Insulet is actively exp...

GNG Research Analysis

GNG Research scores Insulet Corporation (PODD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PODD.

Frequently Asked Questions

Does PODD pay dividends?

Insulet Corporation (PODD) does not currently pay a regular dividend.

What is PODD's P/E ratio?

Insulet Corporation has a price-to-earnings (P/E) ratio of 34.61.

What is PODD's market cap?

Insulet Corporation (PODD) has a market capitalization of $10.26B with a current stock price of $142.43.